T1	PrimaryOutcome 49 77	time to clinical improvement
T2	TimeFrame 78 92	within 28 days
R1	MeasuredAt Arg1:T1 Arg2:T2	
T3	OutcomeDefinition 105 232	patient discharged alive or reduction of 2 points on a 6-point disease severity scale (ranging from 1 [discharge] to 6 [death])
R2	DefinedAs Arg1:T1 Arg2:T3	
T4	SecondaryOutcome 269 278	mortality
T5	TimeFrame 262 268	28-day
R3	MeasuredAt Arg1:T4 Arg2:T5	
T6	SecondaryOutcome 280 297	time to discharge
T7	SecondaryOutcome 307 405	rate of viral polymerase chain reaction (PCR) results turned from positive at baseline to negative
T8	TimeFrame 406 423	at up to 72 hours
R4	MeasuredAt Arg1:T7 Arg2:T8	
T9	OutcomeDefinition 1110 1345	body temperature returned to normal for longer than 3 days, respiratory symptoms significantly improved without the need for oxygen support, and 2 consecutive negative PCR test results from nasopharyngeal swabs at least 24 hours apart.
R5	DefinedAs Arg1:T6 Arg2:T9	
T10	SecondaryOutcome 1396 1412	28-day mortality
T11	OutcomeDefinition 1414 1468	including analysis of time from randomization to death
R6	DefinedAs Arg1:T10 Arg2:T11	
T12	SecondaryOutcome 1474 1501	duration of hospitalization
T13	OutcomeDefinition 1503 1623	including analyses of time from randomization to discharge, time from admission to discharge, and 28-day discharge rates
R7	DefinedAs Arg1:T12 Arg2:T13	
T14	SecondaryOutcome 1633 1735	conversion of nasopharyngeal swab viral PCR results from positive at baseline to negative at follow-up
T15	TimeFrame 1736 1768	assessed at 24, 48, and 72 hours
R8	MeasuredAt Arg1:T14 Arg2:T15	
